TriNetX Appoints Carnell Elliott as Chief Commercial Officer to Boost Growth

TriNetX Welcomes Carnell Elliott as Chief Commercial Officer



Cambridge, Mass. (November 17, 2026) - TriNetX®, the leading global federated health data network, has officially announced the appointment of Carnell Elliott as its new Chief Commercial Officer (CCO). Elliott will be responsible for steering the company’s sales teams, global health partnerships, and marketing strategies during a crucial phase of growth for the organization. Reporting directly to CEO August Calhoun, Elliott's leadership is expected to strengthen TriNetX’s mission in the evolving landscape of healthcare data.

Elliott comes to TriNetX with a robust background in health technology, having previously served as Vice President of Revenue at Henry Schein One, where he effectively led a commercially-driven team overseeing sales, account management, customer success, and market development. His contributions played a vital role in generating remarkable market solutions and driving substantial revenue growth. Prior to his role at Henry Schein, Elliott was Vice President of Sales and Market Development at Change Healthcare, where his efforts resulted in a significant increase of contract bookings from approximately $50 million to an impressive $200 million.

With nearly two decades in experience spanning various positions in technology-driven businesses, Elliott is poised to leverage his expertise deeply rooted in health technology to propel TriNetX forward. His past leadership roles at esteemed companies like Built Technologies and Dell Technologies further solidify his capacity to steer the company toward greater success.

“Carnell understands the expectations clients have from a trusted partner and has proven instrumental in fostering significant growth for commercial organizations,” stated Calhoun. “Having worked with him previously, I can attest to his leadership qualities and commercial acumen. Given the increasing complexity of decisions our clients need to make, these are the very skills we require to advance TriNetX.”

Elliott expressed his excitement regarding his new role, stating, “Making decisions that impact human health with confidence is a challenge that pharmaceutical organizations, healthcare providers, academic researchers, health plans, and other health data users share. TriNetX possesses the data, scientific insights, and expertise needed to help them meet this challenge. My philosophy is straightforward: Work hard, be kind, and be accountable. I am looking forward to collaborating with the sales team to extend these capabilities to more organizations.”

TriNetX operates as the global engine of truth for improved human health, leveraging a secure and interconnected network comprising over 14,200 clinical sites across more than 20 countries. This robust setup delivers trustworthy evidence that can withstand the most rigorous scientific scrutiny worldwide. By merging global data, unyielding integrity, and a unique combination of AI with human intelligence, TriNetX accelerates discovery efforts to enhance health outcomes globally.

For more information on TriNetX or to follow their advancements, visit trinetx.com or connect with them on LinkedIn.

Media Contact:
Karen Tunks
Email: [email protected]

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.